Much EV development prompts digital innovation, yet tried-and-true analog approaches, such as LLCs offer measurable benefits.
Bristol Myers Squibb has expanded its push into radiopharmaceuticals by licensing a prostate cancer therapy developed by Swiss biotech Philochem in a deal that includes an upfront payment of $350 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback